Can-Fite BioPharma Ltd. sell Lokrim
Start price
14.11.21
/
20%
€11.60
Target price
14.11.22
-
Performance (%)
-33.62%
End price
15.11.22
€7.70
Summary
This prediction ended on 15.11.22 with a price of €7.70. Lokrim correctly predicted massive losses of -33.62% for Can-Fite BioPharma Ltd.. Lokrim has 20% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Can-Fite BioPharma Ltd. | - | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Sell Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€21.80
22.02.21
22.02.21
-
22.02.22
22.02.22
-46.79%
14.11.21
14.11.21
Probably not worthwhile Investment
